GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ortin Global Ltd (NSE:ORTINGLOBE) » Definitions » Shiller PE Ratio

Ortin Global (NSE:ORTINGLOBE) Shiller PE Ratio : (As of Sep. 24, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Ortin Global Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Ortin Global Shiller PE Ratio Historical Data

The historical data trend for Ortin Global's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ortin Global Shiller PE Ratio Chart

Ortin Global Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 18.73 19.41 17.97 -

Ortin Global Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.50 29.88 76.52 - -

Competitive Comparison of Ortin Global's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Ortin Global's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ortin Global's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ortin Global's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ortin Global's Shiller PE Ratio falls into.



Ortin Global Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Ortin Global's E10 for the quarter that ended in Jun. 2024 is calculated as:

For example, Ortin Global's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-0.13/155.7889*155.7889
=-0.130

Current CPI (Jun. 2024) = 155.7889.

Ortin Global Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201409 0.917 96.780 1.476
201412 0.063 96.780 0.101
201503 -0.292 97.163 -0.468
201506 0.604 99.841 0.942
201509 0.792 101.753 1.213
201512 0.146 102.901 0.221
201603 -0.521 102.518 -0.792
201606 1.104 105.961 1.623
201609 0.333 105.961 0.490
201612 -0.521 105.196 -0.772
201703 -0.292 105.196 -0.432
201706 0.125 107.109 0.182
201709 0.229 109.021 0.327
201712 0.125 109.404 0.178
201803 0.521 109.786 0.739
201806 0.896 111.317 1.254
201809 -1.292 115.142 -1.748
201812 -0.146 115.142 -0.198
201903 2.146 118.202 2.828
201906 0.313 120.880 0.403
201909 -1.000 123.175 -1.265
201912 -2.125 126.235 -2.622
202003 2.125 124.705 2.655
202006 0.208 127.000 0.255
202009 2.604 130.118 3.118
202012 0.729 130.889 0.868
202103 -2.402 131.771 -2.840
202106 0.110 134.084 0.128
202109 0.070 135.847 0.080
202112 -0.110 138.161 -0.124
202203 -0.560 138.822 -0.628
202206 -0.520 142.347 -0.569
202209 0.100 144.661 0.108
202212 0.560 145.763 0.599
202303 -0.260 146.865 -0.276
202306 0.020 150.280 0.021
202309 -1.380 151.492 -1.419
202312 -3.430 152.924 -3.494
202403 -5.100 153.035 -5.192
202406 -0.130 155.789 -0.130

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ortin Global  (NSE:ORTINGLOBE) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Ortin Global Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Ortin Global's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ortin Global Business Description

Traded in Other Exchanges
Address
Street no. 3, D. No. 1-8-B4, Ground Floor,Block-4, F3 HIG, Baghlingampally, Hyderabad, TG, IND, 500 044
Ortin Laboratories Ltd is an India based engaged in the manufacturing and trading of Pharmaceuticals, Drugs, and Intermediates. Its formulations include anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, antibiotics, antifungal, cephalosporins, and others. Some of its APIs Intermediates include Ciprofloxacin, Tramadol, Efavarenz, Lamivudine, Zudavudine, Nevirapine, Lopinavir, Fluconazole, Triclabendazole, Omeprazole, and others.It earns key revenue from domestic sales.

Ortin Global Headlines

No Headlines